Aberrant nuclear repressor coreceptor 1 localization in human retinoblastoma

Ophthalmic Research

Volumn 49, Issue 4, 2013, Pages 171-176

  Nazha, Bassel ^a,b   Granner, Tamara ^a   Maloney, Shawn ^a   Odashiro, Alexandre N ^a,c   Antecka, Emilia ^a   Burnier Jr , Miguel N ^a  

^a MCGILL UNIVERSITY   (Canada)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

Author keywords

Human retinal progenitor cells; Nuclear receptor corepressor 1; Retinoblastoma; Subcellular localization; Tumorigenesis

Indexed keywords

RECEPTOR INTERACTING PROTEIN 140;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RETINA; RETINA CELL; RETINOBLASTOMA; ANTERIOR EYE CHAMBER; FETUS; NERVE CELL; PATHOLOGIST; PHENOTYPE; PROTEIN EXPRESSION; RETINOBLASTOMA CELL LINE; STEM CELL; TISSUE SECTION; TUMOR DIFFERENTIATION; VITREOUS BODY;

CELL NUCLEUS; CYTOPLASM; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; NEOPLASM PROTEINS; NUCLEAR RECEPTOR CO-REPRESSOR 1; RETINAL NEOPLASMS; RETINOBLASTOMA; SUBCELLULAR FRACTIONS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84871852623     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000345535     Document Type: Article

References (25)

1. Aerts I, Lumbroso-Le Rouic L, Gauthier-Villars M, et al: Retinoblastoma. Orphanet J Rare Dis 2006; 1: 31.
2. Lohmann D: Retinoblastoma. Adv Exp Med Biol 2010; 685: 220-227.
3. Lohmann DR, Gallie BL: Retinoblastoma: revisiting the model prototype of inherited cancer. Am J Med Genet C Semin Med Genet 2004; 129C:23-28.
4. Shields CL, Shields JA: Diagnosis and management of retinoblastoma. Cancer Control 2004; 11: 317-327.
5. Chintagumpala M, Chevez-Barrios P, Paysse EA, et al: Retinoblastoma: review of current management. Oncologist 2007; 12: 1237-1246.
6. Ghisletti S, Huang W, Jepsen K, et al: Cooperative NCoR/SMRT interactions establish a corepressor- based strategy for integration of inflammatory and anti-inflammatory signaling pathways. Genes Dev 2009; 23: 681-693.
7. Jepsen K, Hermanson O, Onami TM, et al: Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell 2000; 102: 753-763.
8. Minucci S, Pelicci PG: Retinoid receptors in health and disease: co-regulators and the chromatin connection. Cell Dev Biol 1999; 10: 215-225.
9. Karagianni P, Wong J: HDAC3: taking the SMRT-N-CoRrect road to repression. Oncogene 2007; 26: 5439-5449.
10. Ishizuka T, Lazar MA: The N-CoR/histone deacetylase 3 complex is required for repression by thyroid hormone receptor. Mol Cell Biol 2003; 23: 5122-5131.
11. Perissi V, Jepsen K, Glass CK, et al: Deconstructing repression: evolving models of corepressor action. Nat Rev Genet 2010; 11: 109-123.
12. Zhang Z, Yamashita H, Toyama T, et al: NCOR1 mRNA is an independent prognostic factor for breast cancer. Cancer Lett 2006; 237: 123-129.
13. Park DM, Li J, Okamoto H, et al: N-CoR pathway targeting induces glioblastoma derived cancer stem cell differentiation. Cell Cycle 2007; 6: 467-470.
14. Hermanson O, Jepsen K, Rosenfeld MG: NCoR controls differentiation of neural stem cells into astrocytes. Nature 2002; 419: 934-939.
15. Singh SK, Hawkins C, Clarke ID, et al: Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
16. Schmitt S, Aftab U, Jiang C, et al: Molecular characterization of human retinal progenitor cells. Invest Ophthalmol Vis Sci 2009; 50: 5901-5908.
17. Stanya KJ, Kao HY: New insights into the functions and regulation of the transcriptional corepressors SMRT and N-CoR. Cell Division 2009; 4: 7.
18. Fernandez-Majada V, Pujadas J, Vilardell F, Capella G, Mayo MW, Bigas A, et al: Aberrant cytoplasmic localization of N-CoR in colorectal tumors. Cell Cycle 2007; 6: 1748-1752.
19. Horlein AJ, Naar AM, Heinzel T, et al: Ligand- independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 1995; 377: 397-404.
20. Battaglia S, Maguire O, Thorne JL, et al: Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion. Carcinogenesis 2010; 31: 1650-1660.
21. Zhang ZH, Yamashita H, Toyama T, et al: Nuclear corepressor 1 expression predicts response to first-line endocrine therapy for breast cancer patients on relapse. Chin Med J (Engl) 2009; 122: 1764-1768.
22. Tzelepi V, Grivas P, Kefalopoulou Z, et al: Expression of estrogen receptor co-regulators NCoR and PELP1 in epithelial cells and myofibroblasts of colorectal carcinomas: cytoplasmic translocation of NCoR in epithelial cells correlates with better (corrected) prognosis. Virchows Arch 2009; 454: 41-53.
23. Li J, Zhuang Z, Okamoto H, et al: Proteomic profiling distinguishes astrocytomas and identifies differential tumor markers. Neurology 2006; 66: 733-736.
24. Rodriguez-Galindo C, Chantada GL, Haik BG, et al: Treatment of retinoblastoma: current status and future perspectives. Curr Treat Options Neurol 2007; 9: 294-307.
25. Lin P, O'Brien JM: Frontiers in the management of retinoblastoma. Am J Ophthalmol 2009; 148: 192-198.